 Piracetam
"Piracetam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound suggested to be both a nootropic and a neuroprotective agent.
| Descriptor ID |
D010889
|
| MeSH Number(s) |
D02.065.064.650 D02.241.081.038.108.650 D03.383.773.812.555
|
| Concept/Terms |
Piracetam- Piracetam
- Pyramem
- Pyracetam
- 2-Pyrrolidone-N-Acetamide
- Pirazetam
Axonyl- Axonyl
- Pfizer Brand of Piracetam
Dinagen- Dinagen
- Hormona Brand of Piracetam
Gabacet- Gabacet
- Sanofi Synthelabo Brand of Piracetam
Geram- Geram
- Vedim Brand of Piracetam
Memo-Puren- Memo-Puren
- Memo Puren
- Alpharma Brand of Piracetam
Nootropil- Nootropil
- UCB Brand of Piracetam
- Normabraïn
- Nootrop
- Nootropyl
Sinapsan- Sinapsan
- Piracetam-RPh
- Piracetam RPh
- Rodleben Brand of Piracetam
Avigilen- Avigilen
- Riemser Brand of Piracetam
|
Below are MeSH descriptors whose meaning is more general than "Piracetam".
Below are MeSH descriptors whose meaning is more specific than "Piracetam".
This graph shows the total number of publications written about "Piracetam" by people in this website by year, and whether "Piracetam" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 | | 2009 | 2 | 0 | 2 | | 2010 | 3 | 1 | 4 | | 2015 | 2 | 0 | 2 | | 2016 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Piracetam" by people in Profiles.
-
Naidech AM, Beaumont J, Jahromi B, Prabhakaran S, Kho A, Holl JL. Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study. Neurology. 2017 Jan 03; 88(1):52-56.
-
Nordli DR, Liou JY. Understanding the comparative effectiveness of treatment in pediatric epilepsy: Call to action. Neurology. 2015 Jun 09; 84(23):2298-9.
-
Issa NP, Fisher WG, Narayanan JT. QT interval prolongation in a patient with LQT2 on levetiracetam. Seizure. 2015 Jul; 29:134-6.
-
Khan O, Cipriani C, Wright C, Crisp E, Kirmani B. Role of intravenous levetiracetam for acute seizure management in preterm neonates. Pediatr Neurol. 2013 Nov; 49(5):340-3.
-
Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011 Apr; 44(4):265-9.
-
Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks. Clin Ther. 2010 Oct; 32(11):1935-50.
-
Merrell RT, Anderson SK, Meyer FB, Lachance DH. Seizures in patients with glioma treated with phenytoin and levetiracetam. J Neurosurg. 2010 Dec; 113(6):1176-81.
-
de la Loge C, Hunter SJ, Schiemann J, Yang H. Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. Epilepsy Behav. 2010 Jul; 18(3):291-8.
-
Arif H, Buchsbaum R, Pierro J, Whalen M, Sims J, Resor SR, Bazil CW, Hirsch LJ. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arch Neurol. 2010 Apr; 67(4):408-15.
-
Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Epilepsia. 2009 Nov; 50(11):2377-89.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|